Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Multiple sclerosis: Bigger brains resist disability in MS.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
[The biological role of sulfatides].
Sodium intake is associated with increased disease activity in multiple sclerosis.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Co-occurrence of multiple sclerosis and Parkinson disease.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Leptin and other adipokines in EAE and MS
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »